Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a six to twelve month period without an identified cause, is a perplexing clinical scenario that often challenges physicians due to its broad differential diagnosis. This article aims to provide a comprehensive approach to evaluating UWL in clinical practice.
Initial evaluation should include a detailed history and physical examination. Key elements to explore include dietary habits, changes in taste or smell, gastrointestinal symptoms, medication use, and psychosocial factors. Physical examination should focus on signs of malnutrition, malignancy, endocrine disorders, or chronic infections.
Laboratory tests should be tailored to each patient’s individual presentation but may include a complete blood count, comprehensive metabolic panel, thyroid function tests, HIV testing, and tumor markers. Imaging studies, such as computed tomography (CT) or positron emission tomography (PET), may be used to identify occult malignancies or systemic diseases.
If initial investigations are unrevealing, specialized testing may be warranted. This can include endoscopic procedures, biopsies, or more advanced imaging studies. In some cases, a watch-and-wait approach may be appropriate, with repeat evaluations over time to see if a diagnosis becomes apparent.
Management of UWL should be guided by the underlying cause, if identified. In cases where no cause is found, symptomatic management, nutritional support, and regular follow-up are key. It is also important to involve a multidisciplinary team, including dietitians and mental health professionals, as appropriate.
UWL is a complex clinical issue that requires a thorough and systematic approach. A detailed history, physical examination, and tailored investigations are crucial in the evaluation process. While the cause of UWL may remain elusive, comprehensive management can help mitigate symptoms and improve patient outcomes.
1.
Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.
2.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
3.
CAR-T cell therapy for cancer causes 'brain fog,' study shows
4.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
5.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
1.
Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications
2.
Screening for Cancer-Related Neuromuscular Weakness: Clinical Approaches and Evidence-Based Strategies
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
5.
Exploring The Causes and Consequences of Low Transferrin Saturation
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation